SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-19-055552
Filing Date
2019-02-28
Accepted
2019-02-28 07:21:19
Documents
48
Period of Report
2019-02-28
Items
Item 7.01: Regulation FD Disclosure
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d703173d8k.htm 8-K 22469
2 EX-99.1 d703173dex991.htm EX-99.1 45123
3 EX-99.2 d703173dex992.htm EX-99.2 19760
4 GRAPHIC g703173ex99_1s10g1.jpg GRAPHIC 246524
5 GRAPHIC g703173ex99_1s11g1.jpg GRAPHIC 253095
6 GRAPHIC g703173ex99_1s12g1.jpg GRAPHIC 355291
7 GRAPHIC g703173ex99_1s13g1.jpg GRAPHIC 389702
8 GRAPHIC g703173ex99_1s14g1.jpg GRAPHIC 250484
9 GRAPHIC g703173ex99_1s15g1.jpg GRAPHIC 403653
10 GRAPHIC g703173ex99_1s16g1.jpg GRAPHIC 408343
11 GRAPHIC g703173ex99_1s17g1.jpg GRAPHIC 357222
12 GRAPHIC g703173ex99_1s18g1.jpg GRAPHIC 301037
13 GRAPHIC g703173ex99_1s19g1.jpg GRAPHIC 251588
14 GRAPHIC g703173ex99_1s1g1.jpg GRAPHIC 233148
15 GRAPHIC g703173ex99_1s20g1.jpg GRAPHIC 447632
16 GRAPHIC g703173ex99_1s21g1.jpg GRAPHIC 340037
17 GRAPHIC g703173ex99_1s22g1.jpg GRAPHIC 343267
18 GRAPHIC g703173ex99_1s23g1.jpg GRAPHIC 351503
19 GRAPHIC g703173ex99_1s24g1.jpg GRAPHIC 251732
20 GRAPHIC g703173ex99_1s25g1.jpg GRAPHIC 281604
21 GRAPHIC g703173ex99_1s26g1.jpg GRAPHIC 258740
22 GRAPHIC g703173ex99_1s27g1.jpg GRAPHIC 327961
23 GRAPHIC g703173ex99_1s28g1.jpg GRAPHIC 265311
24 GRAPHIC g703173ex99_1s29g1.jpg GRAPHIC 312342
25 GRAPHIC g703173ex99_1s2g1.jpg GRAPHIC 669185
26 GRAPHIC g703173ex99_1s30g1.jpg GRAPHIC 395463
27 GRAPHIC g703173ex99_1s31g1.jpg GRAPHIC 364491
28 GRAPHIC g703173ex99_1s32g1.jpg GRAPHIC 268489
29 GRAPHIC g703173ex99_1s33g1.jpg GRAPHIC 501288
30 GRAPHIC g703173ex99_1s34g1.jpg GRAPHIC 501557
31 GRAPHIC g703173ex99_1s35g1.jpg GRAPHIC 305047
32 GRAPHIC g703173ex99_1s36g1.jpg GRAPHIC 389006
33 GRAPHIC g703173ex99_1s37g1.jpg GRAPHIC 265588
34 GRAPHIC g703173ex99_1s38g1.jpg GRAPHIC 344737
35 GRAPHIC g703173ex99_1s39g1.jpg GRAPHIC 434949
36 GRAPHIC g703173ex99_1s3g1.jpg GRAPHIC 214381
37 GRAPHIC g703173ex99_1s40g1.jpg GRAPHIC 414485
38 GRAPHIC g703173ex99_1s41g1.jpg GRAPHIC 265966
39 GRAPHIC g703173ex99_1s42g1.jpg GRAPHIC 465170
40 GRAPHIC g703173ex99_1s43g1.jpg GRAPHIC 208615
41 GRAPHIC g703173ex99_1s44g1.jpg GRAPHIC 461150
42 GRAPHIC g703173ex99_1s4g1.jpg GRAPHIC 313777
43 GRAPHIC g703173ex99_1s5g1.jpg GRAPHIC 293561
44 GRAPHIC g703173ex99_1s6g1.jpg GRAPHIC 371225
45 GRAPHIC g703173ex99_1s7g1.jpg GRAPHIC 251704
46 GRAPHIC g703173ex99_1s8g1.jpg GRAPHIC 440220
47 GRAPHIC g703173ex99_1s9g1.jpg GRAPHIC 327307
48 GRAPHIC g703173g0227233533441.jpg GRAPHIC 4231
  Complete submission text file 0001193125-19-055552.txt   20893401
Mailing Address 131 HARTWELL AVENUE SUITE 320 LEXINGTON MA 02421
Business Address 131 HARTWELL AVENUE SUITE 320 LEXINGTON MA 02421 781-761-4904
Aldeyra Therapeutics, Inc. (Filer) CIK: 0001341235 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36332 | Film No.: 19640416
SIC: 2834 Pharmaceutical Preparations